Meta-analysis of COVID, RSV, flu vaccines for fall provides ‘sea of data’ showing efficacy, safety

The team found that XBB.1.5-adapted COVID-19 mRNA vaccines had a pooled vaccine effectiveness (VE) against hospitalization of 46% to 50% among adults and 37% in immunocompromised adults (those with weakened immune systems). A case-control study…